ANI Pharmaceuticals launches generic version of Cymbalta

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. MRNA
10. SPCX

Go back to ANI Pharmaceuticals launches generic version of Cymbalta

ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules

October 19, 2026 6:55 AM EDT

PRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Duloxetine Delayed-Release Capsules 20, 30 and 60 mg. ANIs Duloxetine Delayed-Release Capsules are the generic version of the reference listed drug (RLD) Cymbalta®.

By launching Duloxetine Delayed-Release Capsules, ANI is providing another alternative of a widely used therapy in a limited player market to assure stable supply. Through close customer and manufacturer partnerships and a focused regulatory effort, we are proud to make this important and widely used therapy... More